Cargando…

Homocysteine as a Predictor Tool in Multiple Sclerosis

Multiple sclerosis (MS) is a progressive and irreversible disease which affects the central nervous system (CNS) with still unknown etiology. Our study aimes to establish the homocysteine pattern that can predict the MS diseases progression and to identify a potential disease progression marker that...

Descripción completa

Detalles Bibliográficos
Autores principales: Mititelu, Radu Razvan, Albu, Carmen Valeria, Bacanoiu, Manuela Violeta, Padureanu, Vlad, Padureanu, Rodica, Olaru, Gabriela, Buga, Ana-Maria, Balasoiu, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Applied Systems srl 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601869/
https://www.ncbi.nlm.nih.gov/pubmed/34816003
http://dx.doi.org/10.15190/d.2021.14
Descripción
Sumario:Multiple sclerosis (MS) is a progressive and irreversible disease which affects the central nervous system (CNS) with still unknown etiology. Our study aimes to establish the homocysteine pattern that can predict the MS diseases progression and to identify a potential disease progression marker that can be easy to perform and non-invasive, in order to predict the diseases outcome. In order to achieve this goal, we included 10 adult RRMS subjects, 10 adult SPMS subjects and 10 age-matched healthy subjects. The homocysteine plasma level was measured using automated latex enhanced immunoassay and the cobalamin and folate measurements were performed using automated chemiluminescence immunoassay (CLIA). HCR was calculated by dividing the homocysteine plasma level by cobalamin plasma level. We found that the homocysteine level in plasma of both RRMS patients and SPMS group are significantly increased compared with the control group. There is a significantly higher concentration of homocysteine in SPMS group compared with the RRMS group. In addition, the HCR is significantly increased in SPMS compared with the RRMS group and is a very good index of disease severity.